Canadian Online Pharmacy

CDER New August 13, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 10, 2012


New and Generic Drug Approvals

August 9, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Advair Diskus 100/50 fluticasone propionate; salmeterol xinafoate Powder; Inhalation Glaxosmithkline Labeling Revision
Advair Diskus 250/50 fluticasone propionate; salmeterol xinafoate Powder; Inhalation Glaxosmithkline Labeling Revision
Advair Diskus 500/50 fluticasone propionate; salmeterol xinafoate Powder; Inhalation Glaxosmithkline Labeling Revision
Advair Hfa fluticasone propionate; salmeterol xinafoate Aerosol, Metered; Inhalation Glaxosmithkline Labeling Revision
Amphetamine Sulfate amphetamine sulfate Tablet; Oral Independence Pharma Llc Approval
Brovana arformoterol tartrate Solution; Inhalation Sunovion Supplement
Clobetasol Propionate clobetasol propionate Shampoo; Topical Perrigo Approval
Diltiazem Hydrochloride diltiazem hydrochloride Injectable; Injection Hikma Farmaceutica Approval
Losartan Potassium; Hydrochlorothiazide losartan potassium; hydrochlorothiazide Tablet; Oral Macleods Pharms Ltd Approval
Marqibo vincristine sulfate Injectable, Liposomal; Injection Talon Therapeutics Approval
Serevent salmeterol xinafoate Powder; Inhalation Glaxo Grp Ltd Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery